Evaluating lung function in severe asthma patients with mucus plugs
Official title: Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
Run by University of Kansas Medical Center · NCT06985225 · Data updated 2026-11-12
This study is testing how mucus plugs in the lungs affect breathing and airflow in people with severe asthma using special imaging techniques.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 8 (estimated) |
| Sponsor | University of Kansas Medical Center Academic / other |
| Locations | 1 site (Kansas City, Kansas) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | July 1, 2026 |
| Trial ID | NCT06985225 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 65 with a physician diagnosis of asthma for over a year and specific blood eosinophil and FeNO levels.
✕Probably not a fit
Patients with significant concomitant medical illnesses or recent respiratory infections may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study uses xenon MRI to assess the impact of mucus plugs on lung ventilation and gas exchange in patients with severe asthma. Mucus plugs will be identified through CT imaging, and the study aims to evaluate the regional functional consequences of these plugs on lung function. Participants will undergo imaging to determine how these obstructions affect airflow and overall respiratory health.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of severe asthma by identifying specific ventilation defects caused by mucus plugs.
How similar studies have gone: While the use of xenon MRI in this context is relatively novel, similar imaging techniques have shown promise in evaluating lung function in other respiratory conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adequate completion of informed consent process with written documentation * Patients 18 - 65 years old * • Physician diagnosis of muco-obstructive pulmonary disease, including cystic fibrosis, severe asthma, chronic obstructive pulmonary disease, or non-cystic fibrosis bronchiectasis for \> 1 year * Able to perform reproducible spirometry according to ATS criteria based on clinical PFTs. Exclusion Criteria: * Respiratory tract infection within the 4 weeks prior to Visit 1 * Body mass index (BMI) \> 30 at Visit 1 * One-time doses such as intra-articular injections require a 4-week washout prior to Visit 1 * ER visit related to pulmonary condition within the previous 4 weeks of Visit 1 * Significant concomitant medical illness, including (but not limited to) heart disease, cancer, uncontrolled diabetes, other chronic lung diseases (determined by the Investigator.) * Resting O2 saturation \<90% with maximum supplemental O2 delivered by nasal canula * Positive urine pregnancy test * Participation in an intervention study (including bronchoscopy) or use of investigative drugs within the past 30 days or plans to enroll in such a trial during the study * Unable or unlikely to complete study assessments in the opinion of the Investigator * Study intervention poses undue risk to patient in the opinion of the Investigator * Conditions that will prohibit MRI scanning determined by the MRI safety screening.
Where it's running
-
University of Kansas Medical Center
Kansas City, Kansas, United States Recruiting
Study contacts
- Study coordinator: Cristal Monge
- Email: chernandez@kumc.edu
- Phone: (913) 945-9399
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oropharyngeal suction and physiotherapy to detect lung bacteria in kids with chronic lung disease
A randomized study will test whether taking samples from the throat with suction, with or without prior physiotherapy, can reliably detect bacteria in children 5–18 with chronic lung disease, compared with standard sample methods.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Seeing if CFTR functioncan be restored in CF through patient cells with rare mutations
This study tests whether testing a patient’s own nasal cells in the lab can predict if CFTR-modulator therapies might help people with uncommon CF mutations.
-
Perceptions and Intentions Around a Change in CF Treatment
This study asks adults with cystic fibrosis currently on ETI whether they would switch to VTD if their doctor offered it and what factors influence that decision.
-
How the CF medicines elexacaftor, tezacaftor, and ivacaftor behave in the body
This study tests how the CF medicines elexacaftor, tezacaftor, and ivacaftor move through the body in patients with cystic fibrosis who are already taking the combination therapy.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.